REPLY
4.5.2022 09:32:07 CEST | Business Wire | Press release
Reply announced today that it has implemented a Quantum Inspired Algorithm, that can be used on both Quantum and traditional computers, for Enel , one of the leading global operators in the electricity and renewable energy production sector. The innovative solution allows Enel to quickly identify the optimal allocation of maintenance activities for operating units distributed across the areas where it operates.
For Enel, which boasts a presence in over 30 countries around the world, a network of over 2.2 million kilometres and 74 million end users, it is essential to coordinate the crews and the allocation and planning of the objectives of the operating units scattered throughout the various territories to guarantee the highest level of service for its customers. Hence the need for operational planning that is as efficient as possible.
The solution developed by Reply is based on the QUBO (Quadratic Unconstrained Binary Optimisation ) mathematical model and can be performed effectively by quantum hardware, known as Quantum Processing Units or QPUs , as well as by classical hardware, known as Graphics Processing Units or GPUs .
Extracting the maximum potential of the GPUs was possible thanks to the MegaQUBO accelerator, a software solution developed by Data Reply to speed up the implementation of Quantum Inspired Optimisation projects . MegaQUBO is a solution certified by Amazon Web Services for use on the AWS Cloud, through the “FTR - Foundational Technical Review” process, which ensures that the software adheres to AWS architectural best practices.
In addition to identifying the optimal allocation of activities, the algorithm created for Enel is also able to calculate the optimal travel routes to reach work destinations, minimising travel times and distances and maximising the time available for actual maintenance work. This leads to a significant increase in productivity and a substantial reduction in operating costs, as well as the corresponding environmental impact .
“Quantum computing makes it possible to solve challenges considered insurmountable until just a few years ago” comments Filippo Rizzante, CTO of Reply . “As we were able to successfully demonstrate based on our experience with Enel, the use of quantum algorithms to solve optimisation problems allows us to obtain significant benefits, not only in the quality of the results, but also in the reduction of processing times. At Reply, we are thus closely exploring different areas in which we can exploit the potential of quantum computing to obtain insights from extremely large and constantly updated databases.”
“The need to implement optimisation strategies on increasingly large territorial areas has correspondingly enhanced the complexity of the problem, to the point that a new and innovative approach was needed”, explains Fabio Veronese, Head of Infrastructure & Networks Digital Hub at ENEL . “The Quantum Inspired approach implemented together with Reply has made it possible to achieve significant and concrete results in the field, and is applicable to both known problems, as well as to new business contexts.”
Reply
Reply [MTA, STAR: REY, ISIN: IT0005282865] specialises in the design and implementation of solutions based on the new communication channels and digital media. Through its network of highly specialised companies, Reply partners with major European corporations in the telecoms and media, industry and services, banking and insurance, and public administration sectors, to devise and develop business models built on the new paradigms of artificial intelligence, big data, cloud computing, digital media, and the Internet of Things. Reply’s services include: Consulting, Systems Integration, and Digital Services. www.reply.com
Data Reply
Data Reply is the Reply group company that specialises in Big Data Analytics, Artificial Intelligence, and Quantum Computing. Thanks to multidisciplinary teams of specialists in Big Data Engineering, Data Science, Intelligent Process Automation, and Quantum & Accelerated Computing, Data Reply supports companies operating in different industrial sectors in their process optimisation journey, through the design and implementation of advanced Quantum Computing solutions and Machine Learning and Artificial Intelligence models. www.data.reply.com
Enel
Enel is the largest European utility by ordinary EBITDA and is present in over 30 countries worldwide, producing energy with around 88 GW of installed capacity. Enel distributes electricity through a network of over 2.2 million kilometres, and with approximately 74 million corporate and domestic end users worldwide, the Group boasts the largest customer base among European competitors. Within the Enel Group, Enel Green Power is the largest private operator in the renewable energy sector in the world, with a managed capacity of over 46 GW from wind, solar, geothermal and hydroelectric plants in Europe, the Americas, Africa, Asia and Oceania. Enel X, Enel’s global advanced energy services business line, is a world leader in demand response, with a total capacity of over 6.3 GW managed globally. The company has installed 110 MW of storage capacity and, in the electric mobility sector, over 100,000 charging points for public and private electric vehicles worldwide.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220504005064/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release
Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
